Evidence map›Paper›PMID 30895241›Full record

ArticleHuman reproduction open2018

Gestational surrogacy. Medical, psychological and legal aspects: 9 years of experience in Mexico.

R Cabra, A Alduncin, J R Cabra, L H Ek, M Briceño, P B Mendoza

Abstract read
In one paragraph

Article in Human reproduction open, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Commercial Surrogacy: An Overview.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

R CabraCentro de Cirugía Reproductiva y Ginecología Reprogyn, Prolongación Usumacinta 2085, Interior 840, Villahermosa, Tabasco, C.P. 86035, Mexico.ORCID https://orcid.org/0000-0003-2096-1995
A AlduncinCentro de Cirugía Reproductiva y Ginecología Reprogyn, Prolongación Usumacinta 2085, Interior 840, Villahermosa, Tabasco, C.P. 86035, Mexico.
J R CabraCentro de Cirugía Reproductiva y Ginecología Reprogyn, Prolongación Usumacinta 2085, Interior 840, Villahermosa, Tabasco, C.P. 86035, Mexico.
L H EkCentro de Cirugía Reproductiva y Ginecología Reprogyn, Prolongación Usumacinta 2085, Interior 840, Villahermosa, Tabasco, C.P. 86035, Mexico.
M BriceñoCentro de Cirugía Reproductiva y Ginecología Reprogyn, Prolongación Usumacinta 2085, Interior 840, Villahermosa, Tabasco, C.P. 86035, Mexico.
P B MendozaCentro de Cirugía Reproductiva y Ginecología Reprogyn, Prolongación Usumacinta 2085, Interior 840, Villahermosa, Tabasco, C.P. 86035, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

study questionWhat are the medical, psychological and legal aspects involved in running a gestational surrogacy (GS) program in Mexico? SUMMARY ANSWER: The correct and complete implementation of a medical protocol, adherence to legality and psychological screening are key elements for the success of a GS program. WHAT IS KNOWN ALREADY: To our knowledge, this is the first reported GS case series in Mexico. STUDY DESIGN SIZE DURATION: This was a retrospective, descriptive study of 135 cycles performed between 2007 and 2016 at a fertility center in Villahermosa, Tabasco, Mexico. PARTICIPANTS/MATERIALS SETTING

methodWe analyzed data from 135 GS cycles, 57 intended parents (IP) and 63 gestational carriers (GC). MAIN RESULTS AND THE ROLE OF CHANCE: GS in Mexico is only allowed in its altruistic mode. The legal requirements for the GCs are age 25-35 years and a complete medical examination that certifies no pregnancy during the last 365 days before embryo transfer and excludes infectious and chronic diseases. The IPs must be aged 25-40 years of age, have Mexican citizenship, and provide life insurance and medical expenses for the GCs. The GC recruitment was carried out by word of mouth. Of the 150+ women that requested information, 89 were identified as possible candidates. In total, 77 underwent the psychological evaluation protocol and nine were rejected owing to behavior and emotional alterations, giving 68 who began the medical selection protocol. Five women were not accepted as they were positive for human papilloma virus, or had experienced endometrial polyposis or recurrent pregnancy loss. Finally, 63 women entered the IVF protocol as GCs. The indications for GS were: hysterectomy 32%, implantation failure 21%, single fathers 14%, maternal medical condition 14%, recurrent pregnancy loss 11%, previous pregnancy complication 5% and uterine pathologies 3%. The mean age of intended mothers was 38.8 years. The average number of embryos transferred per cycle was 1.9, with 22.2% of cycles resulting in pregnancies. The live-birth rate per IP was 33.3%, 18.5% of cycles resulted in live births, with 24% of live births being twins. LIMITATIONS REASONS FOR CAUTION: Owing to the retrospective nature of this study conclusions must be drawn accordingly. WIDER IMPLICATIONS OF THE

findingsAs the first article addressing GS in Latin America, it may serve as a reference for future practice and publications. The results demonstrate the importance of having an assisted reproduction program in the form of GS. STUDY FUNDING/COMPETING INTERESTS: There was no external funding used and there are no conflicts to report.

Indexed as

ARTgestational surrogacygestational surrogacy lawsICSIIVF

Identifiers

PMID30895241
PMCPMC6276654

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.